Description
CJC-1295 stimulates the pituitary gland through GHRH receptor activation, while Ipamorelin enhances growth hormone secretion by targeting ghrelin receptors without significantly influencing cortisol or prolactin levels. Researchers utilize this combination to investigate synergistic effects on IGF-1 production, protein synthesis, muscle recovery, fat metabolism, and cellular repair processes. The complementary mechanisms make this blend valuable in studies focused on endocrine signaling and metabolic adaptation.
The 10mg vial of CJC + Ipamorelin is suitable for researchers initiating investigations into growth hormone pathways, regenerative biology, and metabolic function. It is commonly used in receptor binding studies, cell-based assays, and early-stage in vivo models. This format provides a practical quantity for controlled and focused experimentation.
Progression Peptides supplies CJC + Ipamorelin as a high-purity lyophilized peptide blend with third-party purity verification, ensuring consistency and reliability across research applications. The lyophilized form preserves structural integrity and biological activity when handled according to recommended conditions.
Reconstitution: Reconstitute with bacteriostatic water. Allow to dissolve gently without agitation. The solution should be clear.
Storage: Store in lyophilized form at -20°C. After reconstitution, refrigerate at 2-8°C and use within 30 days.
For research purposes only. Not for human consumption. Not for veterinary use. Sold strictly for laboratory and in vitro research applications.
Reviews
There are no reviews yet.